U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Resources for You (Drugs)
  4. Drug Information for Consumers
  5. Buying & Using Medicine Safely
  6. Medication Health Fraud
  7. Public Notification: Instinct Best Sexual Enjoyment contains hidden drug ingredient
  1. Buying & Using Medicine Safely

Public Notification: Instinct Best Sexual Enjoyment contains hidden drug ingredient

Public Notification: Instinct Best Sexual Enjoyment contains hidden drug ingredient

[1-28-2019] The Food and Drug Administration is advising consumers not to purchase or use Instinct Best Sexual Enjoyment, a product promoted for sexual enhancement. This product was identified during an examination of international mail shipments.

FDA laboratory analysis confirmed that Instinct Best Sexual Enjoyment contains sildenafil, the active ingredient in the FDA-approved prescription drug Viagra, used to treat erectile dysfunction. This undeclared ingredient may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

Instinct Best

Health care professionals and patients should report adverse events or side effects related to the use of this product to FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Note: This notification is to inform the public of products marketed as dietary supplements or conventional foods with hidden drug ingredients and chemicals. These products are typically promoted for sexual enhancement, weight loss, and body building and are often represented as being “all natural.” FDA is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients. Consumers should exercise caution before purchasing any product in the above categories. 

For more information:

Contact FDA

Toll Free
(855) 543-3784, or
(301) 796-3400
Human Drug Information

Division of Drug Information (CDER)

Office of Communications

Feedback Form